In this video soundbite from the ERS-ISIAN 2025 symposium, Dr. Vibeke Backer discusses how Type 2 inflammation drives severe, uncontrolled CRSwNP. It covers key immune cells and biomarkers (e.g., IL-4, IL-5, IL-13, TSLP), global prevalence differences, and the importance of symptom tracking and targeted therapies.

Learn about the disease burden and heterogeneity of chronic obstructive pulmonary disease (COPD).

Learn how loss of smell in CRSwNP is a key symptom for both patients and providers.

Learn how partnering with patients and considering the clinical relevance of symptom improvements can improve patient quality of life
Explore the characteristics of COPD and asthma, focusing on their shared inflammatory mechanisms and key clinical differences.
Learn from Drs. Buchheit and Wagenmann as they discuss key patient traits that predict disease recurrence in CRSwNP.
This infographic explores the emerging concepts of disease activity, disease stability, and disease control in COPD.
Experts from different specialties use a case-based discussion to understand type 2 inflammatory diseases from a nurse practitioner perspective.